Clinical Outcomes and Complications in Two-stage Breast Reconstruction Using Microtextured and Nanotextured Expanders
RA-IBBR-NvsM
Retrospective Analysis of Clinical Outcomes and Complication Rates in Patients Undergoing Two-Stage Breast Reconstruction Using Nano- and Microtextured Tissue Expanders With Evaluation of the Impact of Prior Radiotherapy
1 other identifier
observational
88
1 country
1
Brief Summary
This retrospective observational study evaluates clinical outcomes and complication rates in women who underwent two-staged implant-based breast reconstruction using tissue expanders and implants following mastectomy for breast cancer. The study focuses on comparing postoperative complications associated with nano- and microtextured tissue expanders and assessing the influence of prior radiotherapy on reconstructive outcomes. The hypothesis of the study is that the surface characteristics of tissue expanders and a history of radiotherapy may influence the incidence and type of postoperative complications as well as overall reconstructive success.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2026
CompletedFirst Submitted
Initial submission to the registry
February 24, 2026
CompletedFirst Posted
Study publicly available on registry
March 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2026
CompletedMarch 3, 2026
March 1, 2026
7 months
February 24, 2026
March 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association Between Expander Surface Type and Complications
Incidence of postoperative complications following implant-based breast reconstruction, including seroma, infection, hematoma, capsular contracture, expander rupture, expander rotation, explantation and perception of breast hardness.
Up to 12 months after reconstruction surgery
Study Arms (4)
Nanotextured, post-RT
Nanotextured, post-RT -group of radiated breast tissue prior to the nanotextured-expander surgery
Nanotextured, no-RT
Nanotextured, no-RT - group of not-radiated breast tissue prior to the nanotextured-expander surgery
Microtextured, post-RT
Microtextured, post-RT - group of radiated breast tissue prior to the microtextured-expander surgery
Microtextured, no-RT
Microtextured, no-RT- group of not-radiated breast tissue prior to the microtextured-expander surgery
Eligibility Criteria
Women undergoing two-stage implant based breast reconstruction following mastectomy for breast cancer or as prophylactics at a tertiary care center National Cancer Institute in Bratislava.
You may qualify if:
- History of mastectomy for breast cancer or prophylactic mastectomy
- Undergoing two-stage breast reconstruction
- Reconstruction performed using tissue expanders and implants
- Availability of complete medical documentation
- Regular follow-up visits
You may not qualify if:
- Reconstruction using autologous tissue
- Reconstruction using permanent expander
- Single-stage Reconstruction using implant
- Incomplete clinical documentation
- Missing follow-up data relevant to complication assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Bratislava
Bratislava, 82101, Slovakia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Drahomír Palenčár, MD, PhD
Faculty of Medicine, Comenius University Bratislava
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2026
First Posted
March 2, 2026
Study Start
June 24, 2025
Primary Completion
February 2, 2026
Study Completion
April 28, 2026
Last Updated
March 3, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share